INVA vs GILD: Which Stock is Better?

Side-by-side comparison of Innoviva Inc and Gilead Sciences Inc in 2026

Comparison Updated:

INVA

Innoviva Inc

$24.24

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricINVAGILDWinner
Market Cap$1.76B$170.84BGILD
P/E Ratio7.1520.27INVA
EPS (TTM)$3.30$6.79GILD
Revenue Growth0.2%0.0%INVA
Gross Margin74.9%78.8%GILD

Analyze INVA

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INVA or GILD a better investment?

Comparing INVA and GILD: Innoviva Inc has a market cap of $1.76B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INVA and GILD?

INVA (Innoviva Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INVA or GILD?

Based on P/E ratios, INVA trades at a lower multiple (7.2x vs 20.3x).

Which is growing faster: INVA or GILD?

INVA has higher revenue growth at 0.2% vs 0.0% for GILD.

Which company is more profitable: INVA or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 74.9% for INVA.

Which is the larger company: INVA or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $1.76B for INVA.

Should I buy INVA or GILD in 2026?

Both INVA and GILD have investment merit. INVA trades at $24.24 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INVA and GILD stock?

Key differences: Market Cap ($1.76B vs $170.84B), P/E Ratio (7.2x vs 20.3x), Revenue Growth (0.2% vs 0.0%), Gross Margin (74.9% vs 78.8%).

Popular Stock Comparisons